XML 203 R102.htm IDEA: XBRL DOCUMENT v3.20.4
CAPITAL STOCK - Additional Information (Details) - USD ($)
$ / shares in Units, $ in Millions
1 Months Ended 3 Months Ended 12 Months Ended 91 Months Ended
Jan. 31, 2021
Mar. 31, 2020
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2020
Dec. 31, 2014
Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Options and restricted stock, anti-dilutive (in shares)     4,500,000 5,000,000.0 5,600,000      
Common stock share purchase, shares (in shares)         40,000,000   40,000,000 40,000,000
Treasury shares acquired (in shares)     0 0 7,827,333 40,000,000    
Common stock share repurchase price (in USD per share)           $ 79.18    
Common stock, quarterly dividend (in USD per share)   $ 0.025   $ 0.25        
Common stock, dividends, per share (in USD per share)     $ 0.10 $ 1.00 $ 1.00      
Shares authorized and available for grant (in shares)     14,100,000     14,100,000    
Shares Issued in the period (in shares)     0 0        
Shares exercised in the period (in shares)     0 0 (29,000)      
Intrinsic value of options exercised         $ 0.1      
Stock-settled and cash-settled compensation expensed     $ 40.0 $ 110.0 157.0      
Stock-settled and cash-settled compensation capitalized     7.0 28.0 37.0      
Stock Option                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total compensation cost related to non-vested awards not yet recognized     0.0     $ 0.0    
Restricted Stock                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total compensation cost related to non-vested awards not yet recognized     14.0     14.0    
Stock-settled and cash-settled compensation expensed     39.0 104.0 101.0      
Stock-settled and cash-settled compensation capitalized     $ 6.0 $ 24.0 $ 29.0      
Awards granted during period (in shares)     1,352,000 1,479,000 608,000      
Weighted average grant date fair value per share (in USD per share)     $ 24.60 $ 36.81 $ 45.59      
Restricted Stock | Subsequent Event                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Period in which stock options become exercisable 3 years              
Total compensation cost related to non-vested awards not yet recognized $ 22.0              
Awards granted during period (in shares) 1,354,349              
Weighted average grant date fair value per share (in USD per share) $ 16.18              
Restricted Stock | Subsequent Event | ALTM                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Weighted average grant date fair value per share (in USD per share) $ 48.84              
Phantom Units                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total compensation cost related to non-vested awards not yet recognized     $ 28.0     $ 28.0    
Awards granted during period (in shares)     3,462,000 4,831,000 1,973,000      
Phantom Units | Subsequent Event                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total compensation cost related to non-vested awards not yet recognized $ 71.0              
Awards granted during period (in shares) 4,360,656              
Phantom Units | Subsequent Event | ALTM                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Total compensation cost related to non-vested awards not yet recognized $ 3.0              
Awards granted during period (in shares) 56,836              
In or after 2016 | Stock Option                
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                
Period in which stock options become exercisable     3 years          
Period in which stock options expires after grant date     10 years